Show simple item record

Inosine Analogs as Anti-Leishmanial Agents

dc.contributor.authorTownsend, Leroy B.en_US
dc.contributor.authorNolan, Patricia A.en_US
dc.contributor.authorRainey, Petrieen_US
dc.contributor.authorRobins, Roland K.en_US
dc.contributor.authorFox, Jack J.en_US
dc.contributor.authorSecrist III, John A.en_US
dc.date.accessioned2006-09-08T19:19:11Z
dc.date.available2006-09-08T19:19:11Z
dc.date.issued1985-09en_US
dc.identifier.citationRainey, Petrie; Nolan, Patricia A.; Townsend, Leroy B.; Robins, Roland K.; Fox, Jack J.; Secrist III, John A.; (1985). "Inosine Analogs as Anti-Leishmanial Agents." Pharmaceutical Research 2(5): 217-220. <http://hdl.handle.net/2027.42/41494>en_US
dc.identifier.issn0724-8741en_US
dc.identifier.issn1573-904Xen_US
dc.identifier.urihttps://hdl.handle.net/2027.42/41494
dc.description.abstractSeveral criteria were used to select a number of inosine analogs as potential growth inhibitors of the protozoan parasite Leishmania tropica . Of nine compounds tested, seven showed a high degree of selective toxicity towards L. tropica promastigotes as compared to mouse L1210 cells; these include analogs of formycin B, 7-substituted analogs of 7-deazainosine and analogs of inosine in which the sugar moiety has been modified to confer metabolic stability. The metabolism of 7-deazainosine in L. tropica promastigotes was shown to involve conversion to cytotoxic adenosine nucleotide analogs (tubercidin derivatives) that become incorporated into RNA. The results suggest several new classes of compounds which have potential as anti-leishmanial agents.en_US
dc.format.extent785471 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherKluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Mediaen_US
dc.subject.otherPharmacyen_US
dc.subject.otherMedical Lawen_US
dc.subject.otherBiochemistry, Generalen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherBiomedical Engineeringen_US
dc.subject.otherBiomedicineen_US
dc.titleInosine Analogs as Anti-Leishmanial Agentsen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI, 48109, USAen_US
dc.contributor.affiliationotherLaboratory of Organic Chemistry, Sloan-Kettering Institute, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USAen_US
dc.contributor.affiliationotherSouthern Research Institute, P.O. Box 55305, Birmingham, Alabama, 35255, USAen_US
dc.contributor.affiliationotherDepartment of Biochemistry and Biophysics and Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, 94143, USAen_US
dc.contributor.affiliationotherDepartment of Laboratory Medicine, School of Medicine, University of California, San Francisco, CA, 94143, USAen_US
dc.contributor.affiliationotherCancer Research Center, Department of Chemistry, Brigham Young University, Provo, UT, 84602, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid24272839en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/41494/1/11095_2004_Article_307179.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1023/A:1016360710842en_US
dc.identifier.sourcePharmaceutical Researchen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.